Silverarc Capital Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Silverarc Capital Management’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,956	Closed	-$464K	–	94
2021 Q3	$464K	Buy	40,956 +17,592	+75%	+$211K	0.27%	70
2021 Q2	$238	Buy	+23,364	New	+$240K	0.12%	91

Other funds holding AYLA

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return

DLD Asset Management New York $986M AUM 4.68% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return